p21 gene codon 31 polymorphism is associated with bladder cancer

被引:36
|
作者
Chen, WC
Wu, HC
Hsu, CD
Chen, HY
Tsai, FJ
机构
[1] China Med Coll Hosp, Sch Med, China Med Coll, Dept Med Genet, Taichung 404, Taiwan
[2] China Med Coll Hosp, Sch Med, China Med Coll, Dept Urol, Taichung 404, Taiwan
[3] China Med Coll Hosp, Sch Med, China Med Coll, Dept Obstet & Gynecol, Taichung 404, Taiwan
[4] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30043, Taiwan
来源
UROLOGIC ONCOLOGY | 2002年 / 7卷 / 02期
关键词
p21; codon; 31; polymorphism; bladder cancer; single nucleotide polymorphisms (SNPs);
D O I
10.1016/S1078-1439(01)00152-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The function of p21 is related to cell apoptosis, progression and malignancies. It is thought that p21 is related to cancer formation but is not related to tumor grade. We aimed to investigative the polymorphism of p21 codon 31 as a candidate for the genetic marker of bladder cancer and its progression. The distribution was analyzed in 53 bladder cancer patients, 119 healthy controls in Taiwanese patients. Polymerase chain reaction based restriction analysis was used for the study of the association of p21 codon31 polymorphism with bladder cancer. There was a significant difference in p21 codon 31 polymorphism between the control and the cancer patients (p<0.01). The arginine form was prominent in the cancer patient (per copy of the A allele, odds ratio=2.03, 95% confidence interval=1.23 similar to3.37). Furthermore, the distribution of this polymorphism was significantly different from non-invasive to invasive bladder cancer (p<0.05). Serine heterozygote was more prominent in the invasive group with 25 to 1% respectively when compared with the non-invasive group. The polymorphism of p21 codon 31 is associated with bladder cancer. An individual possessing one allele of arginine form in p21 codon 31 has a higher risk of developing bladder cancer than the serine form. Although the mechanism is unclear, our results show p21 gene is associated with tumor grade, (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 50 条
  • [1] p21 gene codon 31 arginine/serine polymorphism: Non-association with endometriosis
    Hsieh, YY
    Tsai, FJ
    Chang, CC
    Chen, WC
    Tsai, CH
    Tsai, HD
    Lin, CC
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2001, 15 (04) : 184 - 187
  • [2] Association between p21 codon 31 polymorphism and esophageal cancer risk in a Taiwanese population
    Wu, MT
    Wu, DC
    Hsu, HK
    Kao, EL
    Yang, CH
    Lee, JM
    CANCER LETTERS, 2003, 201 (02) : 175 - 180
  • [3] P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21
    Su, L
    Sai, Y
    Fan, R
    Thurston, SW
    Miller, DP
    Zhou, W
    Wain, JC
    Lynch, TJ
    Liu, G
    Christiani, DC
    LUNG CANCER, 2003, 40 (03) : 259 - 266
  • [4] Polymorphisms in codon 31 of p21 and cervical cancer susceptibility in Korean women
    Roh, JW
    Kim, MH
    Kim, JW
    Park, NH
    Song, YS
    Kang, SB
    Lee, HP
    CANCER LETTERS, 2001, 165 (01) : 59 - 62
  • [5] p53 Codon 72 and p21 Codon 31 Polymorphisms and Susceptibility to Cervical Adenocarcinoma in Korean Women
    Roh, Ju-Won
    Kim, Bu Kyung
    Lee, Chae Hyeong
    Kim, Jongseung
    Chung, Hyun Hoon
    Kim, Jae Weon
    Park, Noh-Hyun
    Song, Yong-Sang
    Park, Sang-Yoon
    Kang, Soon-Beom
    ONCOLOGY RESEARCH, 2010, 18 (09) : 453 - 459
  • [6] p53 codon 72 polymorphism and its association with bladder cancer
    Soulitzis, N
    Sourvinos, G
    Dokianakis, DN
    Spandidos, DA
    CANCER LETTERS, 2002, 179 (02) : 175 - 183
  • [7] Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme
    Cheng, Wen-Yu
    Shen, Chiung-Chyi
    Liang, Yea-Jiuen
    Chiao, Ming-Tsang
    Yang, Yi-Chin
    Hsieh, Wan-Yu
    Lin, Cheng-Hui
    Chen, Jun-Peng
    BMC CANCER, 2023, 23 (01)
  • [8] Polymorphism at codon 31 of CDKN1A (p21) as a predictive factor for bevacizumab therapy in glioblastoma multiforme
    Wen-Yu Cheng
    Chiung-Chyi Shen
    Yea-Jiuen Liang
    Ming-Tsang Chiao
    Yi-Chin Yang
    Wan-Yu Hsieh
    Cheng-Hui Lin
    Jun-Peng Chen
    BMC Cancer, 23 (1)
  • [9] P21 Ser31Arg Polymorphism and Cervical Cancer Risk A Meta-Analysis
    Li, Ya
    Liu, Fei
    Tan, Shiqiao
    Li, Shangwei
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (03) : 445 - 451
  • [10] Quantitative assessment of the relationship between p21 Ser31Arg polymorphism and cervical cancer
    Ma, Yingchun
    Zhang, Yanwei
    Lin, Li
    Guo, Xiumin
    Wu, Yu
    Wen, Wenjuan
    Li, Fengli
    Liu, Peishu
    TUMOR BIOLOGY, 2013, 34 (06) : 3887 - 3892